| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.53 | 0.0009 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.004 |